Matches in Wikidata for { <http://www.wikidata.org/entity/Q53376132> ?p ?o ?g. }
- Q53376132 description "2015 nî lūn-bûn" @default.
- Q53376132 description "2015年の論文" @default.
- Q53376132 description "2015年学术文章" @default.
- Q53376132 description "2015年学术文章" @default.
- Q53376132 description "2015年学术文章" @default.
- Q53376132 description "2015年学术文章" @default.
- Q53376132 description "2015年学术文章" @default.
- Q53376132 description "2015年學術文章" @default.
- Q53376132 description "2015年學術文章" @default.
- Q53376132 description "2015年學術文章" @default.
- Q53376132 description "2015年學術文章" @default.
- Q53376132 description "2015年學術文章" @default.
- Q53376132 description "2015年學術文章" @default.
- Q53376132 description "2015년 논문" @default.
- Q53376132 description "article científic" @default.
- Q53376132 description "article scientific" @default.
- Q53376132 description "article scientifique (publié 2015)" @default.
- Q53376132 description "articol științific" @default.
- Q53376132 description "articolo scientifico" @default.
- Q53376132 description "artigo científico (publicado na 2015)" @default.
- Q53376132 description "artigo científico (publicado na 2015)" @default.
- Q53376132 description "artigo científico" @default.
- Q53376132 description "artikull shkencor" @default.
- Q53376132 description "artikulong pang-agham" @default.
- Q53376132 description "artykuł naukowy" @default.
- Q53376132 description "artículo científico publicado en 2015" @default.
- Q53376132 description "artículu científicu" @default.
- Q53376132 description "bilimsel makale" @default.
- Q53376132 description "bài báo khoa học" @default.
- Q53376132 description "mokslinis straipsnis" @default.
- Q53376132 description "naučni članak" @default.
- Q53376132 description "scienca artikolo" @default.
- Q53376132 description "scientific article" @default.
- Q53376132 description "teaduslik artikkel" @default.
- Q53376132 description "tieteellinen artikkeli" @default.
- Q53376132 description "tudományos cikk" @default.
- Q53376132 description "vedecký článok" @default.
- Q53376132 description "vetenskaplig artikel" @default.
- Q53376132 description "videnskabelig artikel (udgivet 2015)" @default.
- Q53376132 description "vitenskapelig artikkel" @default.
- Q53376132 description "vitskapeleg artikkel" @default.
- Q53376132 description "vědecký článek" @default.
- Q53376132 description "wetenschappelijk artikel" @default.
- Q53376132 description "wissenschaftlicher Artikel" @default.
- Q53376132 description "επιστημονικό άρθρο" @default.
- Q53376132 description "мақолаи илмӣ" @default.
- Q53376132 description "мақолаи илмӣ" @default.
- Q53376132 description "наукова стаття, опублікована в серпні 2015" @default.
- Q53376132 description "научна статия" @default.
- Q53376132 description "научная статья" @default.
- Q53376132 description "научни чланак" @default.
- Q53376132 description "научни чланак" @default.
- Q53376132 description "գիտական հոդված" @default.
- Q53376132 description "מאמר מדעי" @default.
- Q53376132 description "سائنسی مضمون" @default.
- Q53376132 description "مقالة علمية" @default.
- Q53376132 description "مقالهٔ علمی" @default.
- Q53376132 description "২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q53376132 description "บทความทางวิทยาศาสตร์" @default.
- Q53376132 description "სამეცნიერო სტატია" @default.
- Q53376132 name "Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial." @default.
- Q53376132 name "Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial." @default.
- Q53376132 type Item @default.
- Q53376132 label "Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial." @default.
- Q53376132 label "Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial." @default.
- Q53376132 prefLabel "Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial." @default.
- Q53376132 prefLabel "Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial." @default.
- Q53376132 P1433 Q53376132-4B6413DA-D699-4987-9E8D-F5CEECCFFD92 @default.
- Q53376132 P1476 Q53376132-CFEC5F63-4EAF-4B2B-9DCD-484F983C5EA1 @default.
- Q53376132 P2093 Q53376132-10B535F0-7DAB-4304-BE38-F725DE8FAB55 @default.
- Q53376132 P2093 Q53376132-33CD30DC-781F-4AFC-AC28-0E4306A0BACD @default.
- Q53376132 P2093 Q53376132-4D10C5BC-2BE5-450E-B71C-20E204FE01DE @default.
- Q53376132 P2093 Q53376132-678FBFB0-4C1C-4E0B-A481-52029874DE23 @default.
- Q53376132 P2093 Q53376132-7AAC4A58-CE03-418E-B63D-B7CB91ECE4BF @default.
- Q53376132 P2093 Q53376132-A15653CB-E013-481B-A1C7-FD5B27C7021B @default.
- Q53376132 P2093 Q53376132-AE736892-D770-496A-A91F-6DE20B34A096 @default.
- Q53376132 P2093 Q53376132-B658A9B2-6B50-49B2-93E3-2BD95FDDE144 @default.
- Q53376132 P2093 Q53376132-E5861A58-5FC6-461B-9A00-4E3002F263FA @default.
- Q53376132 P304 Q53376132-169468EC-1C95-4E8A-9FC5-612C97F56D07 @default.
- Q53376132 P31 Q53376132-030DD42F-7EDD-4C5E-93E4-FF4129D39F09 @default.
- Q53376132 P356 Q53376132-D2D5BE48-BB06-4BB8-AF3E-4685B2F5C89A @default.
- Q53376132 P407 Q53376132-DFA793F2-1997-4983-A83E-5A3AF1248A8B @default.
- Q53376132 P433 Q53376132-035A3ADC-9C73-41F1-A410-83C26DD8776D @default.
- Q53376132 P478 Q53376132-13AD492F-8E75-45AD-9C70-4CAD66F78ABB @default.
- Q53376132 P50 Q53376132-CFD50B4E-B4D1-41C7-BD81-BFEF130C82DE @default.
- Q53376132 P50 Q53376132-D18DDFAE-0B2E-4243-A01C-CFEFA32BA7C3 @default.
- Q53376132 P577 Q53376132-99DF6D8A-23E8-494B-8716-E8FAC7613DD9 @default.
- Q53376132 P698 Q53376132-ADCD325B-80E6-42AE-B7B0-612E7AC2758B @default.
- Q53376132 P921 Q53376132-419C7E96-8820-4D52-B103-A273AD8E96A6 @default.
- Q53376132 P921 Q53376132-61EAEBD1-43A2-42C6-8D04-B5F3DDC06F05 @default.
- Q53376132 P921 Q53376132-85F702D6-F33A-452F-AEF7-B67CED794130 @default.
- Q53376132 P921 Q53376132-968AB219-8027-4CED-A29F-5E613A5821B4 @default.
- Q53376132 P921 Q53376132-B6295078-3ECD-472A-A418-693AF0637EBB @default.
- Q53376132 P921 Q53376132-CAF3E898-44AA-45AE-A3B7-E5B824F55545 @default.
- Q53376132 P921 Q53376132-D3466D47-0C57-41F6-AF02-D5B11B6DF80A @default.
- Q53376132 P356 JCO.2015.63.1408 @default.
- Q53376132 P698 26282651 @default.
- Q53376132 P1433 Q400292 @default.
- Q53376132 P1476 "Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial." @default.
- Q53376132 P2093 "Alexander Reuss" @default.